Robert Lisicki
Chief Executive Officer at ZURA BIO LIMITED
Net worth: - $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Kimberly Ann Davis | F | 56 | 4 years | |
| Matthew Szot | M | 50 | 2 years | |
| Steven Schoch | M | 64 | 3 years | |
| Sandeep Kulkarni | M | 43 | 2 years | |
| Someit Sidhu | M | 34 | 2 years | |
| Glynn Wilson | M | 74 | 1 years | |
| Parvinder Thiara | M | 39 | 1 years | |
| Jennifer Locke | F | - |
Adiso Therapeutics, Inc.
 Adiso Therapeutics, Inc. BiotechnologyHealth Technology Adiso Therapeutics, Inc. creates medicines to treat inflammatory diseases with the goal of improving the lives of patients and their families. Adiso Therapeutics is based in Concord, MA. The company believes that current therapeutic approaches are often inadequate and can pose significant safety concerns for patients. Scott T. Megaffin has been the CEO of the company since 2022. | 2 years |
| Arnout Ploos van Amstel | M | 58 | 1 years | |
| Neil Graham | M | 65 | 1 years | |
| Quang Pham | M | 59 | 2 years | |
| Michael Howell | M | 47 | 2 years | |
| John Murphy | M | 73 | 1 years | |
| Jennifer Jarrett | F | 53 | 1 years | |
| Steven Zelenkofske | M | 65 | 1 years | |
| Amit Munshi | M | 56 | 1 years | |
| Jason Robert Dinges | M | 48 |
Adiso Therapeutics, Inc.
Adiso Therapeutics, Inc. BiotechnologyHealth Technology Adiso Therapeutics, Inc. creates medicines to treat inflammatory diseases with the goal of improving the lives of patients and their families. Adiso Therapeutics is based in Concord, MA. The company believes that current therapeutic approaches are often inadequate and can pose significant safety concerns for patients. Scott T. Megaffin has been the CEO of the company since 2022. | - |
| Douglas Losordo | M | 65 | 2 years | |
| Theresa Lowry | F | 50 | - | |
| Verender Badial | M | 51 | 1 years | |
| Scott T. Megaffin | M | 61 |
Adiso Therapeutics, Inc.
Adiso Therapeutics, Inc. BiotechnologyHealth Technology Adiso Therapeutics, Inc. creates medicines to treat inflammatory diseases with the goal of improving the lives of patients and their families. Adiso Therapeutics is based in Concord, MA. The company believes that current therapeutic approaches are often inadequate and can pose significant safety concerns for patients. Scott T. Megaffin has been the CEO of the company since 2022. | 2 years |
| Gary Whale | M | 50 | 1 years | |
| Lamine Mbow | M | - | 3 years | |
| Dave Brady | M | - | - | |
| Marlyn Mathew | F | - | - | |
| Harjit Singh | M | - | - | |
| Jeffrey Cole | M | 56 | - | |
| Kiran Nistala | M | 51 | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Christopher Cabell | M | 54 | 3 years | |
| Steven W. Spector | M | 59 | 19 years | |
| Manmeet Singh Soni | M | 46 | 3 years | |
| Randall E. Woods | M | 72 | 13 years | |
| Joan Schmidt | F | 60 | - | |
| Katharine Knobil | M | 60 | 2 years | |
| Nawal Ouzren | F | 45 | 1 years | |
| Craig B. Bleifer | M | - |
Daiichi Sankyo, Inc.
 Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | 18 years |
| Michael Paolucci | M | 64 | - | |
| Sandra Clarke | F | 55 |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | 1 years |
| Igor Matushansky | M | 51 |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | 2 years |
| Paul Streck | M | 60 | 2 years | |
| Laurie Stelzer | F | 56 | 2 years | |
| Paul Audhya | M | 51 | 3 years | |
| Kevin Lind | M | 47 | 4 years | |
| Mahmoud Ghazzi | M | - |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | 5 years |
| Danesha Dixon Smith | F | 51 |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | 5 years |
| Preston Klassen | M | 55 | 3 years | |
| Chadwick J. Orevillo | M | - | 3 years | |
| Suzanne Zoumaras | F | 60 | 3 years | |
| Douglas Manion | M | 64 | 1 years | |
| Vincent Aurentz | M | 56 | 6 years | |
| Lorenz Muller | M | 60 |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | 7 years |
| Scott Gottlieb | M | 51 |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | 2 years |
| Javad Shahidi | M | - |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 53 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Robert Lisicki
- Personal Network
